Related Experiment Video
Updated: Jul 15, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Risk and Prognosis of Upper Extremity Deep Vein Thrombosis
Yusuke Endo1,2, Naoki Unno1,2,3, Naoto Yamamoto3
1Division of Vascular Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Insights
Upper extremity deep vein thrombosis (UEDVT) often occurs with malignancy and central vein catheters. While complications like pulmonary embolism are rare, UEDVT associated with cancer has a very poor prognosis.
Area of Science:
- Vascular Medicine
- Hematology
- Oncology
Background:
- Upper extremity deep vein thrombosis (UEDVT) is a significant clinical concern.
- Understanding its risk factors, presentation, and outcomes is crucial for patient management.
Purpose of the Study:
- To investigate the clinical features, treatment, and outcomes of patients with upper extremity deep vein thrombosis (UEDVT).
Main Methods:
- Retrospective review of 76 UEDVT patients.
- Analysis of patient demographics, thrombus location, treatment modalities, and survival data.
Main Results:
- Malignancy (67.1%) and indwelling central vein (CV) catheters (57.9%) were common comorbidities.
- The right internal jugular vein was the most frequent thrombus site (35.3%).
- Mortality was high (52.6%), primarily due to malignancy (82.5%), despite low rates of recurrence or pulmonary embolism (PE).
Conclusions:
- UEDVT frequently coexists with malignancy and CV catheter use.
- While PE risk is low, UEDVT in cancer patients carries a poor prognosis.
- Oral anticoagulants, including direct oral anticoagulants (DOACs), are common treatments.
Abstract:
Objectives: We aimed to investigate the clinical features of upper extremity deep vein thrombosis (UEDVT). Methods: We retrospectively reviewed the background, thrombus site, treatment, and outcome of 76 UEDVT patients. Results: Of the 76 UEDVT patients, 44 (57.9%) were men, and 51 (67.1%) were complicated by malignancy, 44 (57.9%) had an indwelling central vein (CV) catheter, 8 (10.5%) had concomitant pulmonary embolization (PE), and 33 (43.3%) were symptomatic. Regarding the thrombus site, the right internal jugular vein was the most common, with 30 cases (35.3%). As regards the treatment method, 53 patients (69.7%) received oral anticoagulants. In 2015, when direct oral anticoagulants (DOACs) was covered by insurance, there were 44 UEDVT cases, of which 34 (77.3%) received DOACs. Outcomes at a mean observation period of 37.5±41.5 months included 40 deaths (52.6%) with a mean survival of 16.3±21.3 months. The most common cause of death was malignancy, with 33 cases (82.5%). Conclusion: In the background of UEDVT, the combination of indwelling CV catheter placement and malignancy was frequently observed. While the risk of recurrence or PE complications is low, the prognosis of UEDVT complicated by malignancy is extremely poor.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Pulmonary Embolism III: Nursing Management

